Michael Germain, MD
Enriched profileRTANE Professor of Medicine, Tufts University School of Medicine; Medical Director of Renal Transplantation · Renal and Transplant Associates of New England (RTANE)
Michael Germain is RTANE Professor of Medicine, Tufts University School of Medicine; Medical Director of Renal Transplantation at Renal and Transplant Associates of New England (RTANE). OpenAlex indexes 274 publications with 9,028 citations (h-index 50); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michael J. Germain, MD, is RTANE Professor of Medicine, Tufts University School of Medicine at Renal and Transplant Associates of New England (RTANE), Springfield, MA. The public record shows 274 publications with 9,028 citations (h-index 50), centered on ESRD / Dialysis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 30 companies.
- Most recent indexed publication: 2024 · Nephrology, dialysis, transplantation
- Top research focus: ESRD / Dialysis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
Sponsor: Michael Germain
Industry payments
Updated 27 Aug 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year202511 payments$10,982openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20251 payment
- Otsuka America Pharmaceutical, Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.8%Calcium channel blocker16.9%Amlodipine Besylate91%Nifedipine Er9%Part D<11 patientsBeta blocker10.9%Carvedilol61%Metoprolol Succinate39%Part D≥17 patientsMetabolism & gastrointestinal
18.7%SGLT2 inhibitor15.3%Farxiga42%Jardiance32%Synjardy Xr15%Dapagliflozin11%Part D<11 patientsMetabolic Alkalinizer2%Potassium Citrate Er100%Part D<11 patientsNervous system
5.2%Gabapentinoids3%Gabapentin100%Part D<11 patientsSSRI2.2%Paroxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis.
Nephrology, dialysis, transplantation
Clinical Trial2024 - Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches.
Clinical kidney journal
Review2021 - Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25(th) Acute Disease Quality Initiative (ADQI) Workgroup.
Nature reviews. Nephrology
Erratum2020 - COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
Nature reviews. Nephrology
Review2020 - Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue Instrument.
Clinical journal of the American Society of Nephrology
Article2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/cv/michael-germain-md-1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Michael-Germain
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Board Certified
American Board of Internal Medicine, Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
American Board of Internal Medicine, Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →global.oup.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- Faculty
Division of Nephrology, UMass Chan Medical School–Baystate (Baystate Health) Nephrology Fellowship
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →baystatehealth.org ↗ - Consultant
Baystate Medical Center, Springfield, MA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →trinityhealthofne.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus